Oric Pharmaceuticals Cash Flow Statement (2019-2026) | ORIC

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-66.20M-23.29M-29.44M-25.57M-28.50M-123.11M-37.81M-54.56M-43.70M-163.77M-118.61M-59.21M-89.08M-212.47M-44.63M-95.44M-116.54M-34.38M-140.30M-115.56M
Depreciation and Depletion (Quarter)
0.22M0.23M0.25M0.25M0.22M0.28M0.25M0.26M0.26M0.26M0.26M0.27M0.27M0.30M0.30M0.31M0.29M0.30M0.27M0.26M
Share-based Compensation (Quarter)
3.40M3.50M3.94M4.09M3.29M3.13M3.61M3.83M3.86M3.92M4.96M5.00M5.06M5.20M6.55M6.57M5.63M6.28M6.90M7.09M
Cash from Operations (Quarter)
-12.14M-16.28M-22.72M-17.78M-19.32M-15.33M-20.63M-21.14M-19.64M-24.27M-30.19M-25.62M-28.80M-28.05M-32.53M-30.84M-25.11M-22.48M-32.44M-31.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.33M-0.15M-0.04M0.09M0.37M0.62M0.86M1.26M1.92M2.12M2.23M2.30M1.95M1.63M0.88M0.59M0.59M0.24M-0.16M-0.29M
Depreciation & Amortization (CF) (Quarter)
0.22M0.23M0.25M0.25M0.22M0.28M0.25M0.26M0.26M0.26M0.26M0.27M0.27M0.30M0.30M0.31M0.29M0.30M0.27M0.26M
Change in Working Capital
Change in Accured Expenses (Quarter)
1.64M2.48M-3.26M-0.16M0.50M1.44M-0.79M-0.82M3.91M0.98M-5.76M3.80M0.76M3.03M-7.91M-0.25M1.36M-0.45M-3.32M2.22M
Investing Activities
Capital Expenditures (Quarter)
0.23M0.39M0.72M0.67M0.40M0.29M0.31M0.41M0.08M0.06M0.22M0.33M0.42M0.22M0.39M0.06M0.04M0.23M0.00M0.36M
Change in Acquisitions & Divestments (Quarter)
43.00M37.50M10.00M60.73M60.22M56.48M36.99M53.23M49.99M52.74M67.50M77.50M77.50M87.50M47.50M55.00M62.50M60.00M60.00M
Cash from Investing Activities (Quarter)
35.07M0.35M-90.66M-46.20M-0.69M28.30M12.78M-19.31M-57.83M20.96M-61.87M18.28M23.07M42.66M22.45M-76.93M-110.53M16.98M-17.98M11.86M
Financing Activities
Other financing activities (Quarter)
0.10M0.81M0.02M0.06M0.00M0.00M0.03M0.03M0.20M0.29M0.13M0.01M0.25M0.03M0.75M0.94M1.25M0.15M
Change in Capital Stock
Shares Issued (Quarter)
5.26M5.27M2.81M3.09M1.67M6.69M1.76M1.91M3.38M8.72M10.82M10.95M11.10M11.25M6.97M14.25M14.13M13.90M9.44M17.15M
Net Equity Issued and Repurchased (Quarter)
50.00M25.00M85.00M125.00M133.93M110.44M60.88M
Misc.
Cash from Financing Activities (Quarter)
48.59M0.81M0.02M0.41M0.00M24.79M85.17M0.03M0.45M125.03M0.82M0.13M0.57M0.01M134.30M109.45M1.50M61.14M0.83M
Change in Cash (Quarter)
71.52M-15.12M113.36M-290.29M-20.00M37.76M-7.85M44.72M-77.44M-2.85M32.98M-6.53M-5.60M15.18M-10.07M26.53M-26.20M-4.00M10.73M-18.91M
Free Cash Flow (Quarter)
-12.38M-16.67M-23.44M-18.44M-19.72M-15.62M-20.94M-21.55M-19.72M-24.33M-30.40M-25.96M-29.21M-28.27M-32.92M-30.91M-25.15M-22.71M-32.44M-31.96M
Net Cash Flow (Quarter)
71.52M-15.12M-113.36M-63.56M-20.00M37.76M-7.85M44.72M-77.44M-2.85M32.98M-6.53M-5.60M15.18M-10.07M26.53M-26.20M-4.00M10.73M-18.91M